MIRA Pharmaceuticals Inc MIRA

US Pharmaceuticals

$0.62 ▲ +0.32% (+$0.00)

⬆️ Above Yest. High 📅 Earnings This Week

Open $0.62

Prev Close $0.62

Day Range $0.60 – $0.64

52W Range $0.51 – $1.69

Market Cap $26.01M

Beta 1.74

EPS (TTM) $-0.32

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2023-08-03
Shares Out.	42,020,000
Website	mirapharmaceuticals.com/ ↗
Phone	18133695150
Employees	2
Revenue	$0
Gross Profit	$0
Net Income	-$1.2M
Free Cash Flow	-$4.6M
Total Assets	$8.2M
Total Liabilities	$40,823
Equity	$8.2M

About MIRA Pharmaceuticals Inc

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

MIRA Pharmaceuticals Inc is a publicly traded company under the ticker symbol MIRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.